Zhang et al. reported that there were no significant differences in PD-L1 expression between NSCLC with BRAF mutation and wild-type, whereas BRAF mutation was associated with higher TMB compared with BRAF wild-type [86]. The gene discussed is BRAF; the disease is non-small cell lung carcinoma.